(Q38486082)

English

Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study

scientific article published on 17 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study (English)

1 reference

Europe PubMed Central

3 September 2017

Nicholas Talley

3

object named as

N J Talley

1 reference

Europe PubMed Central

3 September 2017

author name string

S Veldhuyzen van Zanten

1

1 reference

Europe PubMed Central

3 September 2017

P Wahlqvist

2

1 reference

Europe PubMed Central

3 September 2017

K Halling

4

1 reference

Europe PubMed Central

3 September 2017

N Vakil

5

1 reference

Europe PubMed Central

3 September 2017

K Lauritsen

6

1 reference

Europe PubMed Central

3 September 2017

N Flook

7

1 reference

Europe PubMed Central

3 September 2017

T Persson

8

1 reference

Europe PubMed Central

3 September 2017

E Bolling-Sternevald

9

1 reference

Europe PubMed Central

3 September 2017

STARS II Investigators

10

1 reference

Europe PubMed Central

3 September 2017

language of work or name

0 references

publication date

17 August 2011

1 reference

Europe PubMed Central

3 September 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

3 September 2017

34

1 reference

Europe PubMed Central

3 September 2017

7

1 reference

Europe PubMed Central

3 September 2017

714-723

1 reference

Europe PubMed Central

3 September 2017

Health-related quality of life in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

An international comparison of the burden of illness in patients with dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Guidelines for the management of dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

American gastroenterological association technical review on the evaluation of dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

The Hospital Anxiety And Depression Scale

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Functional dyspepsia affects women more than men in daily life: a case-control study in primary care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Functional dyspepsia, delayed gastric emptying, and impaired quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Systematic review: the impact of gastro-oesophageal reflux disease on work productivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Ecological momentary assessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04789.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04789.X

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38486082&oldid=1761957345"